Award notice Supplies

Nintedanib en pirfenidon

Notice published in Dutch. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: AZ Delta vzw
Roeselare
Place of performance: 8800 Roeselare, West Flanders
Amount awarded: €1,080,061 excl. VAT
Planned end of contract: 30 September 2030
likely re-tender around March 2030
Bids received: 3
Form: Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure: Open procedure
Any company may submit a bid.
Publication: 6 October 2026
Notice language: Dutch

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Deze opdracht omvat het sluiten van een raamovereenkomst voor de levering van nintedanib en pirfenidon voor een periode van één jaar en driemaal stilzwijgend verlengbaar voor telkens één jaar. Het betreft nitedanib en pirfenidon voor de behandeling van pulmonaire fibrose.

Awarded to

2 lots

Nintedanib
Pirfenidon

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below: €269,390
Median: €449,863
A quarter above: €962,736

Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

Contract	Winner	Amount
Aflibercept AZ Delta vzw · 8 September 2026	Celltrion Healthcare Netherlands BV	€4,424,940
Denosumab SC AZ Delta vzw · 16 July 2026	Amgen NV	€389,080
Tocilizumab IV AZ Delta vzw · 18 June 2026	Celltrion Healthcare Netherlands BV	€385,370
Parenterale cytostatica AZ Delta vzw · 7 April 2026	Celltrion Healthcare Netherlands BV Sandoz NV Accord Healthcare BV Arega Pharma NV Aurobindo NV Fresenius Kabi NV Pharmanovia Benelux BV Grindeks-Kalceks Belgium BV Viatris BV EG NV Pharma Mar BV Roche NV	€3,950,688
Infliximab AZ Delta vzw · 4 August 2025	Sandoz NV	€1,450,176

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 687563-2026.